Journal ArticleOPEN ACCESS

Sativex: oromucosal cannabinoid spray for spasticity in MS

  • Chaplin S
  • Dobson R
Prescriber (2010) 21(20) 34-37
DOI: 10.1002/psb.684
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Sativex is an oromucosal cannabinoid spray licensed as add‐on therapy for moderate to‐severe spasticity in multiple sclerosis. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and side‐effects, and Dr Ruth Dobson discusses its place in the treatment of spasticity.

Cite

CITATION STYLE

APA

Chaplin, S., & Dobson, R. (2010). Sativex: oromucosal cannabinoid spray for spasticity in MS. Prescriber, 21(20), 34–37. https://doi.org/10.1002/psb.684

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free